Antimicrobial Resistance News and Research

RSS

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Researchers at the University of Southampton are to study the use of Chinese Herbal Medicines in treating recurrent urinary tract infections (RUTIs), in the first clinical trial of its kind in the UK.

25 May 2016

ECDC assessment outlines current and future CRE risks for human health

Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of effective treatment options.

25 May 2016

New Quick Reference Guide set to improve antibiotic prescribing

A Tasmanian initiative to provide a ‘Quick Reference Guide’ to antibiotic prescribing in the community has been embraced by general practitioners (GPs) and is set to improve prescribing, delegates at the National Medicines Symposium in Canberra have heard.

19 May 2016

World Veterinary Day: OIE pays tribute to veterinarians who played crucial role in protecting global health

On World Veterinary Day (30 April), the OIE pays tribute to the crucial role played by veterinarians in protecting global health. This year, the event focuses on the opportunities for veterinarians to continue their training and extend their expertise in areas related to the ‘One Health’ concept. To achieve this, World Veterinary Day promotes collaboration with the human health sector in the coverage of issues such as zoonoses, food safety and antimicrobial resistance.

5 May 2016

Promising method may help identify new antimicrobials to target CRE infection

In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.

30 Apr 2016

ECCMID 2016: Global experts join to fight antimicrobial resistance

Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.

12 Apr 2016

Pooled analysis from seven clinical studies demonstrates consistent efficacy for ceftazidime-avibactam in the treatment of multi-drug resistant gram-negative bacteria

AstraZeneca has presented positive data demonstrating the efficacy of the investigational antibiotic, ceftazidime-avibactam (CAZ-AVI), in treating patients with ceftazidime-resistant Gram-negative infections, which are increasingly resistant to most available antibiotics, often precipitating the need for clinicians to reach for agents previously reserved for last-line use.

12 Apr 2016

Keynotes announced for ECCMID 2016

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) previews some of the keynote lectures at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). The globe’s most prominent infection specialists will be gathering at its annual congress in Amsterdam from 9 – 12 April 2016.

8 Apr 2016

NTU researchers make breakthrough to tackle growing concern of antibiotic resistance

Scientists at Nanyang Technological University, Singapore have discovered that antibiotics can continue to be effective if bacteria's cell-to-cell communication and ability to latch on to each other are disrupted.

2 Apr 2016

World TB Day 2016: WHO calls to Unite to End TB

In advance of World TB Day, to be observed on 24 March, the World Health Organization is calling on countries and partners to Unite to End TB.

22 Mar 2016

BD MedMined Surveillance Advisor finishes first in Infection Control and Monitoring category

BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.

15 Mar 2016

Startling lack of resistance genes discovered in intensively-farmed beef

In the first study to track antibiotic resistance in intensively-farmed beef, scientists discovered a "startling" lack of resistance genes in meat.Meanwhile, in soil and faeces samples from cattle pens they found genes resistant to a powerful "last resort" class of antibiotics called carpabemens that aren't used in the livestock industry. These genes may have jumped from humans or companion animals to livestock, or could even be present at low levels in the wider environment.

9 Mar 2016

Giving feedbacks to GPs could cut unnecessary prescriptions of antibiotics

Sending general practitioners (GPs) in England a letter giving feedback on their antibiotic prescribing habits could cut unnecessary prescriptions of antibiotics, according to the first nationwide randomised trial of its kind involving over 1500 GP practices, published in The Lancet.

23 Feb 2016

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.

30 Jan 2016

New breakthrough drug shows promise to fight antibiotic-resistant infections

A New York pharmaceutical company, TGV-Laboratories, has developed a groundbreaking drug that shows promise in treating a wide variety of antibiotic-resistant fungal and bacterial infections.

28 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Enterobacteriaceae refer to the family of bacteria such as E. coli and Klebsiella that are bacterial pathogens most frequently associated with hospital-acquired infections

25 Jan 2016

Johnson & Johnson joins industry-wide call to address growing problem of antimicrobial resistance

Johnson & Johnson today announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland.

21 Jan 2016

Research could lead to new treatments to prevent blockages, urinary tract infections faced by long-term catheter users

New research could lead to new treatments to prevent blockages and urinary tract infections experienced by many long-term catheter users.

14 Dec 2015

UC San Diego biologists develop a method to screen natural products for new antibiotics

Biologists at UC San Diego have found that a method they developed to identify and characterize new antibiotics can be employed to screen natural products quickly for compounds capable of controlling antibiotic resistant bacteria.

11 Dec 2015